| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Veradermics, Inc | Chief Executive Officer, Director | Stock Option (Right to Buy) | 556,399 | 03 Feb 2026 | Direct | ||
| Veradermics, Inc | Chief Executive Officer, Director | Common Stock | 234,872 | 05 Feb 2026 | Direct | ||
| Veradermics, Inc | Chief Executive Officer, Director | Series A Convertible Preferred Stock | 0 | 05 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MANE | Veradermics, Inc | 03 Feb 2026 | 3 | $0 | 4 | Chief Executive Officer, Director | 05 Feb 2026, 19:00 |
| MANE | Veradermics, Inc | 03 Feb 2026 | 0 | $0 | 3 | Chief Executive Officer, Director | 03 Feb 2026, 21:05 |